scispace - formally typeset
S

Signe Adamberg

Researcher at Tallinn University of Technology

Publications -  20
Citations -  472

Signe Adamberg is an academic researcher from Tallinn University of Technology. The author has contributed to research in topics: Bacteria & Gut flora. The author has an hindex of 10, co-authored 16 publications receiving 322 citations. Previous affiliations of Signe Adamberg include National Institute of Chemical Physics and Biophysics.

Papers
More filters
Journal ArticleDOI

Influence of gemcitabine chemotherapy on the microbiota of pancreatic cancer xenografted mice

TL;DR: Understanding chemotherapy side effects may explain the lack of activity or the chemoresistant processes and it may help to set up strategies to improve the effectiveness of therapy.
Journal ArticleDOI

Degradation of Fructans and Production of Propionic Acid by Bacteroides thetaiotaomicron are Enhanced by the Shortage of Amino Acids.

TL;DR: The study revealed the influence of amino acids on fructan metabolism in B. thetaiotaomicron and showed that defined growth media are invaluable in elucidating quantitative metabolic profiles of the bacteria.
Journal ArticleDOI

Bacterial polysaccharide levan as stabilizing, non-toxic and functional coating material for microelement-nanoparticles

TL;DR: It is suggested that the combination of levan and nutritionally importantmicroelements in the form of NPs serves as a first step towards a novel "2 in 1" approach for food supplements to provide safe and efficient delivery of microelements for humans and support beneficial gut microbiota with nutritional oligosaccharides.
Journal ArticleDOI

Levan Enhances Associated Growth of Bacteroides, Escherichia, Streptococcus and Faecalibacterium in Fecal Microbiota

TL;DR: The study shows that the capacity of levan and possibly also other dietary fibers/prebiotics to modulate the composition and function of colon microbiota can be predicted by using isothermal microcalorimetry of fecal samples linked to metabolite and consortia analyses.
Journal ArticleDOI

Engineered Resistant-Starch (ERS) Diet Shapes Colon Microbiota Profile in Parallel with the Retardation of Tumor Growth in In Vitro and In Vivo Pancreatic Cancer Models.

TL;DR: A positive effect of the ERS diet on composition and metabolism of mouse fecal microbiota shown in vitro is associated with the decrease of tumor progression in the in vivo PC xenograft mouse model, suggesting that engineered dietary interventions could be supportive as a synergistic approach to enhance the efficacy of existing cancer treatments in pancreatic cancer patients.